Literature DB >> 19632833

Atovaquone derivatives as potent cytotoxic and apoptosis inducing agents.

Jing Zhou1, Lei Duan, Huaming Chen, Xiaomei Ren, Zhang Zhang, Fengtao Zhou, Jinsong Liu, Duanqing Pei, Ke Ding.   

Abstract

2-Piperazinyl naphthoquinones (2) and 2-piperidinyl naphthoquinones (3) were designed and synthesized as new cytotoxic and apoptosis inducing agents by utilizing the anti-parasite drug atovaquone as lead compound. Several compounds displayed significantly improved cytotoxic activities against a panel of cancer cell lines than that of atovaquone. These compounds also induced apoptosis through activating pro-apoptotic caspases 9 and 3.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19632833     DOI: 10.1016/j.bmcl.2009.07.044

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

1.  Atovaquone enhances doxorubicin's efficacy via inhibiting mitochondrial respiration and STAT3 in aggressive thyroid cancer.

Authors:  Zhuo Lv; Xintong Yan; Liying Lu; Chun Su; Yin He
Journal:  J Bioenerg Biomembr       Date:  2018-04-23       Impact factor: 2.945

2.  Microbial Metabolism of Atovaquone and Cytotoxicity of the Produced Phase I Metabolite.

Authors:  Eliane de Oliveira Silva; Natália Dos Santos Gonçalves; Raquel Alves Dos Santos; Niege Araçari Jacometti Cardoso Furtado
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-10       Impact factor: 2.441

3.  Down-regulation of phosphoglucomutase 3 mediates sulforaphane-induced cell death in LNCaP prostate cancer cells.

Authors:  Chan-Hee Lee; Soo-Jin Jeong; Sun-Mi Yun; Ji-Hyun Kim; Hyo-Jung Lee; Kwang Seok Ahn; Suk-Hyun Won; Hyun Seok Kim; Hyo-Jeong Lee; Kyoo-Seok Ahn; Shudong Zhu; Chang-Yan Chen; Sung-Hoon Kim
Journal:  Proteome Sci       Date:  2010-12-16       Impact factor: 2.480

4.  Exploring gene knockout strategies to identify potential drug targets using genome-scale metabolic models.

Authors:  Abhijit Paul; Rajat Anand; Sonali Porey Karmakar; Surender Rawat; Nandadulal Bairagi; Samrat Chatterjee
Journal:  Sci Rep       Date:  2021-01-08       Impact factor: 4.379

5.  New Amino Naphthoquinone Derivatives as Anti-Trypanosoma cruzi Agents Targeting Trypanothione Reductase.

Authors:  Christian Espinosa-Bustos; Mariana Ortiz Pérez; Alonzo Gonzalez-Gonzalez; Ana María Zarate; Gildardo Rivera; Javier A Belmont-Díaz; Emma Saavedra; Mauricio A Cuellar; Karina Vázquez; Cristian O Salas
Journal:  Pharmaceutics       Date:  2022-05-25       Impact factor: 6.525

6.  In Vitro and In Silico Study to Assess Toxic Mechanisms of Hybrid Molecules of Quinone-Benzocaine as Plastoquinone Analogues in Breast Cancer Cells.

Authors:  Ayse Mine Yilmaz Goler; Ayse Tarbin Jannuzzi; Nilüfer Bayrak; Mahmut Yıldız; Hatice Yıldırım; Masami Otsuka; Mikako Fujita; Mohamed O Radwan; Amaç Fatih TuYuN
Journal:  ACS Omega       Date:  2022-08-15

7.  Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells.

Authors:  Marco Fiorillo; Rebecca Lamb; Herbert B Tanowitz; Luciano Mutti; Marija Krstic-Demonacos; Anna Rita Cappello; Ubaldo E Martinez-Outschoorn; Federica Sotgia; Michael P Lisanti
Journal:  Oncotarget       Date:  2016-06-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.